A crucial role in 
advancing medical research

Evaluation of the efficacy and tolerance of a new therapy, therapeutic monitoring, development of innovative tests for clinical diagnosis ... Clinical trial biology plays a crucial role in advancing medical research and improving the care and treatment of patients at all stages of the disease. 

For more than 15 years, we have been supporting companies in the pharmaceutical, biotechnology and in vitro diagnostic sectors by leveraging our expertise in medical biology.

In May 2026, Cerba Advanced Pathology by Cerba achieved CAP (College of American Pathologists) accreditation, a globally recognized mark of quality.

background
  • Image
    Icon_Temps bleu
    > 15

    years' experience in clinical trial biology

  • Image
    Icon_microscope bleu
    100

    clinical trials in progress

  • Image
    Localisation
    17 000

    m2  technical platform

A New CAP Accreditation

Cerba Advanced Pathology has achieved accreditation from the College of American Pathologists (CAP). This strategic initiative brought together complementary expertise from quality, technical operations, medical laboratory science, clinical trials, and leadership teams. By combining these diverse capabilities, we successfully met CAP requirements and implemented robust solutions tailored to the needs of healthcare industry stakeholders worldwide.

Bloc_2025_CerbaResearch.png

Close collaboration 
with Cerba Research

Most of our clinical trial biology activity is carried out in collaboration with Cerba Research, a Cerba Healthcare Group entity specialized in clinical trials and present on five continents. 

Bloc_2025_PourquoiChoisirCerba.png

Why choose Cerba for your clinical trial projects?

We also directly support industrial companies with their clinical trial projects, particularly in the fields of oncology and neurodegenerative diseases. Cerba remains a preferred partner for clinical trial biology thanks to:

• its high level of medical, scientific, and technical expertise

• its cutting-edge technological platform allowing access to the most innovative tests

• its extensive patient recruitment

• its large capacities in logistics, pre-analytical, analytical, and biological sample storage

• And finally, its extreme adaptability: Cerba supports you at all stages of the project in a personalized manner and according to all your specific needs (custom testing, custom storage, custom data reporting, custom method validation, etc.)

Bloc_2025_MarquageCEIVDR.png

IVDR CE mark with Cerba Xpert

At Cerba Xpert, we support IVD manufacturers at every stage in the development of their devices. We offer unique access to collections of biological samples, both retrospective and prospective, essential for validating the performance of diagnostic tests. By combining this invaluable resource with access to reference diagnostic technologies and platforms and our in-depth knowledge of regulations, we help manufacturers to successfully complete their clinical and performance studies and obtain the IVDR CE mark.